The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...

Medical device, pharmaceutical, and life sciences expert tapped to lead Company’s technology strategy and global engineering ...

As of 2 PM, the Sensex was up 190.90 points (0.24%) at 78,175.28, while the Nifty50 gained 74.05 points (0.31%) to trade at ...

Merck plans to launch US subcutaneous version of Keytruda on October 1 Healthcare & Pharmaceuticalscategory · 12:15 AM UTC · Updated ago The Merck logo is ... greenlights GSK's drug for ...

NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

The FDA approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new ...

GSK (GSK) is pushing the UK government to give pharmaceutical companies more access to its public health data in order to accelerate drug ...

GSK PLC closed 18.56% short of its 52-week high of £18.24, which the company achieved on May 16th.

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

The Food and Drug Administration on Tuesday approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker ...